MYSZ earnings analysis
What we found in MYSZ's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative MD&A, so revenue, margin, EPS, cash flow, and period-over-period trends cannot be assessed from the available text. Controls were deemed effective as of June 30, 2026, and a legal claim was settled for NIS 425,000, approximately $143. The principal updated risk is Nasdaq listing compliance: MVLS was approximately $2.3 million as of August 13, 2026, versus a contemplated $5.0 million threshold, while the related rule remains stayed pending SEC review.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Controls assessed effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026.
- Legal claim settled
- The company resolved the Shimon Shukron litigation for NIS 425,000, approximately $143, payable in three monthly installments; the full amount was accrued as a current liability as of June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- MVLS below Nasdaq threshold
- As of August 13, 2026, the company’s Market Value of Listed Securities was approximately $2.3 million, below the $5.0 million Nasdaq threshold. If the stayed rule becomes effective and the company remains below the threshold for 30 consecutive business days, Nasdaq could issue a Staff Delisting Determination and immediately suspend trading.
- Ongoing Nasdaq compliance risk
- Nasdaq continued-listing standards require a minimum bid price of $1.00 for 30 consecutive trading days and at least $2.5 million in shareholders’ equity. The company states it has previously fallen out of compliance with certain standards, creating ongoing delisting risk.
- Near-term settlement obligation
- The company accrued NIS 425,000, approximately $143, as a current liability for the Shimon Shukron settlement. Although the claim was resolved, the payment creates a near-term cash obligation payable over three monthly installments.
What they said about what is next.
The supplied 10-Q extract contains no quantitative revenue or EPS outlook. No explicit guidance was provided in the available MD&A text.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 14, 2026
- MySize, Inc. reported a revenue of $2,394,000 for Q4 2026, an increase from $1,479,000 in Q4 2025. The net loss widened to $1,476,000 from $1,060,000 year-over-year, with gross and operating margins declining…
- 10-K · April 15, 2026
- MySize positions itself as an integrated “size, commerce, circularity and distribution” platform built from four business units (Naiz Fit, Orgad, Percentil, Ten Peacks) and multiple 2025 acquisitions intended to create…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing MYSZ makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever